Prelude Therapeutics secures $60M from Incyte option deal
Go back to Prelude Therapeutics secures $60M from Incyte option deal| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 98.22 -0.77 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.99 | 52 Week High | $118.49 | |||
| Open | $99.58 | 52 Week Low | $55.00 | |||
| Day High | $99.62 | P/E | N/A | |||
| Day Low | $96.09 | EPS | $-0.56 | |||
| Volume | 4,058,624 | |||||
| (NASDAQ: PRLD) | Delayed: 4.32 -0.03 (0.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.35 | 52 Week High | $ | |||
| Open | $4.38 | 52 Week Low | $ | |||
| Day High | $4.64 | P/E | N/A | |||
| Day Low | $4.16 | EPS | $ | |||
| Volume | 1,076,627 | |||||
